PDLI

PDLI touches 200-day moving average at 9.32 - 11/25 - 12:04 PM ET

BRIEF-PDL BioPharma announces record date for spin-off of biotechnology operations - 11/19 - 09:13 AM ET

PDL BioPharma Announces Record Date for Spin-Off of Biotechnology Operations - 11/19 - 09:06 AM ET

PDLI touches 50-day moving average at 9.19 - 11/19 - 12:30 PM ET

BRIEF-PDL BioPharma Q3 results - 11/06 - 04:12 PM ET

PDL BioPharma Reports Third Quarter 2008 Financial Results and Updates 2008 Guidance for Royalty Revenues - 11/06 - 04:02 PM ET

PDLI: Q3 Earnings Call @ 16:30 ET Today [delayed] - 11/06 - 01:51 PM ET

BRIEF-PDL BioPharma names CEO - 11/06 - 09:40 AM ET

PDL BioPharma Appoints John P. McLaughlin to Become President and CEO Upon Completion of Spin-Off of Biotechnology Assets - 11/06 - 09:01 AM ET

PDLI touches 200-day moving average at 10.00 - 11/03 - 01:23 AM ET

PDL BioPharma Announces November 6 Webcast of Third Quarter 2008 Financial Results Conference Call - 10/24 - 04:00 PM ET

PDL BioPharma Elects Paul Sandman and John McLaughlin to Its Board of Directors - 10/10 - 04:01 PM ET

PDL BioPharma names new president and CEO - 09/26 - 09:29 AM ET

PDLI: To Present At UBS Global Life Sciences Conference @ 14:00 ET [delayed] - 09/25 - 12:23 PM ET

PDL BioPharma Names Faheem Hasnain President and Chief Executive Officer - 09/25 - 08:01 AM ET

PDL BioPharma Announces Participation at the UBS Global Life Sciences Conference and Webcast Presentation on September 25 - 09/23 - 07:15 PM ET

PDL BIOPHARMA DOWN 4.6% AT $11.06; DOWNGRADED TO UNDERWEIGHT AT JPMORGAN - 09/11 - 10:25 AM ET

PDL BioPharma Drops In Pre-Market On Downgrade - 09/11 - 08:53 AM ET

PDL BioPharma (PDLI) NewsBite - PDLI Tumbles on Downgrade - 09/11 - 02:33 AM ET

PDL BioPharma Challenges Support On Increased Volume - 08/29 - 10:45 AM ET

Page 1 of 7     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index